CMPX vs GM · $367.4M cap vs P/E 7.5, rev $185.02B
Compass Therapeutics Inc. (CMPX) versus General Motors Company (GM) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
General Motors Company (GM) is a auto manufacturers company listed on US. It is led by Mary Barra.
CMPX does not have a complete income-statement cache yet.
Latest reported GM revenue for 2025-12-31 was $185.02B. Net income was $2.70B. Revenue was down 1.3% from 2024-12-31 to 2025-12-31. GM currently screens at market cap $51.33B and trailing P/E 7.5.
CMPX currently screens at market cap $367.4M. GM currently screens at market cap $51.33B and trailing P/E 7.5.
Not investment advice. Open the CMPX and GM stock pages for the full models.
Not investment advice.